Evidence map›Paper›PMID 36580310›Full record

ArticleInvestigative ophthalmology & visual science2022

Fluorescence Lifetime and Spectral Characteristics of Subretinal Drusenoid Deposits and Their Predictive Value for Progression of Age-Related Macular Degeneration.

Sebastian Weber, Rowena Simon, Linda-Sophia Schwanengel, Christine A Curcio, Regine Augsten, Daniel Meller, Martin Hammer

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Fluorescence lifetime imaging ophthalmoscopy (FLIO) of patients with neovascular age-related macular degeneration before and after treatment with intravitreal ranibizumab.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sebastian WeberDepartment of Ophthalmology, University Hospital Jena, Jena, Germany.
Rowena SimonDepartment of Ophthalmology, University Hospital Jena, Jena, Germany.
Linda-Sophia SchwanengelDepartment of Ophthalmology, University Hospital Jena, Jena, Germany.
Christine A CurcioDepartment of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Regine AugstenDepartment of Ophthalmology, University Hospital Jena, Jena, Germany.
Daniel MellerDepartment of Ophthalmology, University Hospital Jena, Jena, Germany.
Martin HammerDepartment of Ophthalmology, University Hospital Jena, Jena, Germany.
Jena University Hospital · DEUniversity of Alabama at Birmingham · US

Funding

Functionally Validated Structural Endpoints for Early AMDR01EY029595 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURCIO, CHRISTINE A, OWSLEY, CYNTHIA · 2019 to 2023
$4.1M
A hyperspectral approach to RPE fluorophores in AMDR01EY027948 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ACH, THOMAS, CURCIO, CHRISTINE A · 2017 to 2025
$3.8M
NEI NIH HHS R01 EY027948NEI NIH HHS R01 EY029595
6 · The paper itself

Abstract

Purpose: To measure fundus autofluorescence (FAF) lifetimes and peak emission wavelengths (PEW) of subretinal drusenoid deposits (SDD) in age-related macular degeneration (AMD) and their development over time. Methods: Fluorescence lifetime imaging ophthalmoscopy (FLIO) was performed in 30 eyes with optical coherence tomography (OCT)-confirmed early or intermediate AMD and SDD. Contrasts of mean lifetimes in short- (SSC) and long-wavelength channels (LSC), PEW, and relative fluorescence intensity were determined as differences of the respective measures at individual SDD and their environment. Measurements were made at baseline and at follow-up intervals 1 (13-36 months) and 2 (37-72 months), respectively. Results: Of 423 SDD found at baseline, 259, 47, and 117 were hypoautofluorescent, isoautofluorescent, and hyperautofluorescent, respectively. FAF lifetimes of SDD were significantly longer than those of their environment by 14.5 ps (SSC, 95% confidence interval [CI], 13.3-15.7 ps) and 3.9 ps (LSC, 3.1-4.7 ps). PEW was shorter by 1.53 nm (1.07-1.98 nm, all contrasts P < 0.001) with higher contrasts for hyperfluorescent SDD. Over follow-up, SDD tended to hyperautofluorescence (relative intensities increased by 3.4% [95% CI, 2.9%-4.1%; P < 0.001] in follow-up 2). Hyperautofluorescence was associated with disruption of the ellipsoid zone on OCT. Disease progression to late-stage AMD was associated with higher lifetime contrast in SSC (15.9ps [14.2-17.6 ps] vs. 11.7 ps [9.9-13.5 ps], P < 0.001) at baseline. Conclusions: SDD show longer FAF lifetimes and shorter PEW than their environments. A high lifetime contrast of SDD in SSC might predict disease progression to late-stage AMD.

Indexed as

Macular DegenerationRetinal DrusenDisease ProgressionFluorescein AngiographyHumansOphthalmoscopyRetinaTomography, Optical Coherence

Identifiers

PMID36580310
PMCPMC9804024
OpenAlexW4313331379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.